Skip to main content

NTLA

Intellia Therapeutics, Inc.
Last price
$13.77
As of

Active signals for NTLA

No recent signals on NTLA in the last 180 days.

Top institutional holders of NTLA (13F)

FundMarket value% portfolioQoQ
D. E. Shaw & Co., Inc.$73.4M0.04%+7.4%
TWO SIGMA INVESTMENTS, LP$60.3M0.05%+74.4%
D. E. Shaw & Co., Inc.$47.9M0.03%+139.2%
TWO SIGMA INVESTMENTS, LP$42.3M0.06%,
D. E. Shaw & Co., Inc.$38.5M0.02%,
TWO SIGMA INVESTMENTS, LP$24.3M0.03%+10.2%
RENAISSANCE TECHNOLOGIES LLC$15M0.02%+156.9%
RENAISSANCE TECHNOLOGIES LLC$11.2M0.01%,
CITADEL ADVISORS LLC$6.8M0.00%+101.2%
CITADEL ADVISORS LLC$6.5M0.00%,
Point72 Asset Management, L.P.$3M0.01%,
Bridgewater Associates, LP$2M0.01%,
Point72 Asset Management, L.P.$346K0.00%+12.0%
Point72 Asset Management, L.P.$217K0.00%-86.2%

Sourced from quarterly 13F filings with the U.S. Securities and Exchange Commission.

Recent SEC filings, NTLA

See more NTLA signals as they fire

Kresmion publishes filings, 13F flows, on-chain whale activity, and cross-asset signals in real time. Sign in to track NTLA in your watchlist and get notified the moment a new signal fires.

Track NTLA on Kresmion →